Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PRELP Regulates Cell-Cell Adhesion and EMT and Inhibits Retinoblastoma Progression.
Hopkins J, Asada K, Leung A, Papadaki V, Davaapil H, Morrison M, Orita T, Sekido R, Kosuge H, Reddy MA, Kimura K, Mitani A, Tsumoto K, Hamamoto R, Sagoo MS, Ohnuma SI. Hopkins J, et al. Among authors: kosuge h. Cancers (Basel). 2022 Oct 8;14(19):4926. doi: 10.3390/cancers14194926. Cancers (Basel). 2022. PMID: 36230849 Free PMC article.
PRELP secreted from mural cells protects the function of blood brain barrier through regulation of endothelial cell-cell integrity.
Davaapil H, Hopkins J, Bonnin N, Papadaki V, Leung A, Kosuge H, Tashima T, Nakakido M, Sekido R, Tsumoto K, Sagoo MS, Ohnuma SI. Davaapil H, et al. Among authors: kosuge h. Front Cell Dev Biol. 2023 Oct 23;11:1147625. doi: 10.3389/fcell.2023.1147625. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37936982 Free PMC article.
Exon-skipping events in candidates for clinical trials of morpholino.
Nakano S, Ozasa S, Yoshioka K, Fujii I, Mitsui K, Nomura K, Kosuge H, Endo F, Matsukura M, Kimura S. Nakano S, et al. Among authors: kosuge h. Pediatr Int. 2011 Aug;53(4):524-9. doi: 10.1111/j.1442-200X.2011.03330.x. Pediatr Int. 2011. PMID: 21342350
Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.
Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group. Umemoto S, et al. Hypertens Res. 2017 Apr;40(4):376-384. doi: 10.1038/hr.2016.158. Epub 2016 Dec 1. Hypertens Res. 2017. PMID: 27904156 Free PMC article. Clinical Trial.
92 results